Menu
Search
|

Menu

Close
X

ICAD Inc ICAD.OQ (NASDAQ Stock Exchange Capital Market)

4.50 USD
+0.00 (+0.00%)
As of Mar 18
chart
Previous Close 4.50
Open 4.81
Volume 64,888
3m Avg Volume 36,053
Today’s High 4.81
Today’s Low 4.39
52 Week High 6.10
52 Week Low 2.50
Shares Outstanding (mil) 17.25
Market Capitalization (mil) 76.93
Forward P/E 7.97
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
19
FY17
28
FY16
26
EPS (USD)
FY18
-0.341
FY17
0.289
FY16
-0.633
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
7.97
11.03
Price to Sales (TTM)
vs sector
2.90
153.93
Price to Book (MRQ)
vs sector
7.64
1.83
Price to Cash Flow (TTM)
vs sector
7.67
14.98
Total Debt to Equity (MRQ)
vs sector
62.38
17.50
LT Debt to Equity (MRQ)
vs sector
49.44
10.22
Return on Investment (TTM)
vs sector
46.73
14.16
Return on Equity (TTM)
vs sector
66.21
15.43

EXECUTIVE LEADERSHIP

Michael Klein
Executive Chairman of the Board, Chief Executive Officer, Since 2018
Salary: --
Bonus: --
R. Scott Areglado
Interim Chief Financial Officer, Vice President, Corporate Controller, Since 2019
Salary: --
Bonus: --
Stacey Stevens
Senior Vice President - Marketing and Strategy, Since 2006
Salary: $270,000.00
Bonus: --
Jonathan Go
Chief Technology Officer, Since 2019
Salary: $255,000.00
Bonus: --
Rakesh Patel
Director, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Technology
Industry: Computer Hardware
Address:

98 Spit Brook Rd Ste 100
NASHUA   NH   03062-5737

Phone: +1603.8825200

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

SPONSORED STORIES